How Mass Tort Lead Generation Works: From First Ad to Signed Case

Every campaign starts with a written definition of who the case is for. That definition usually comes from the litigation's case criteria: the product or substance involved, the dates of use or exposure, the diagnosis that must appear in the claimant's medical history, and any exclusions. If your firm has not written these criteria down, that is the first task, because every later step depends on them.

A firm accepting cases for a medical device, for example, might require that the device was implanted after a certain year, that the claimant experienced a specific complication, and that the complication was documented by a physician. A claimant without all of those facts is not a case, no matter how sincere the inquiry. Building the criteria first is what separates lead generation from generic advertising.

The people a mass tort campaign wants to reach are not searching for a lawyer. They are searching for answers about their own situation: what a diagnosis means, whether a recall affects them, what symptoms other people have reported, or whether there is any help available. Effective advertising meets them in that moment with plain, factual language about the product and the injury.

Good creative never promises an outcome. It says, in effect, that people who used a product and developed a condition may be entitled to learn more about their options, and it invites them to answer a few questions. The advertising also has to comply with state bar rules on lawyer advertising, which is why the firm itself should approve the final language before anything runs. We cover the compliance side in detail in our article on mass tort marketing rules.

A landing page does two jobs at once. It gives the claimant a short, credible explanation of why they are being asked questions, and it collects the contact information and consent that make a compliant follow-up possible. The page should load fast on a phone, because most claimants arrive from a mobile feed or a mobile search result.

The consent record matters as much as the contact information. A well-built page records the exact form the claimant saw, the claims the page made, the timestamp, the IP address, and the consent language the claimant agreed to. Years later, when the litigation is still active and the firm needs to show how each claimant was acquired, that record is the difference between a documented inquiry and a dispute.

Screening is where an inquiry becomes a lead. The claimant answers the questions that map to the case criteria: whether they used the product, when, what they were diagnosed with, and who treated them. The questions are built from the firm's own criteria, and a claimant is only delivered after answering them.

The goal of screening is not to be clever. It is to remove the two categories that waste a firm's time: people who do not fit the litigation at all, and people who cannot be reached. Screening questions should be short enough to complete on a phone, specific enough to separate real matches from curiosity, and consistent with the facts the litigation actually requires. A claimant who finishes screening and matches every criterion is exactly what the firm paid for.

A qualified claimant delivered three days later is a much weaker case than one delivered the same hour. People forget details, lose motivation, and talk to other firms. Real-time delivery means the claimant's answers, contact information, and consent record arrive in the firm's intake queue the moment screening is complete.

Delivery should be exclusive. When the same claimant is sold to several firms or aggregators, the result is duplicate signups, confusion over who represents the person, and a claimant who has already said yes to someone else by the time your intake team calls. Lead Search Pros sells the leads from each campaign to one firm and never resells them.

Everything before this step only creates the opportunity. The signed case comes from intake: how fast the firm calls, how prepared the caller is, and how easy the firm makes it to sign. Claimants in mass torts often take more touches than accident victims, because there is no emergency pushing them to act today. A fixed follow-up cadence across calls, texts, and emails over several days is standard practice.

Because mass tort cases run for years, the firm should also treat intake as a record-keeping function. Notes about what the claimant said on each call, copies of the medical documentation they mention, and the dates of every attempt all become part of the case file. Firms that build intake around speed and documentation convert dramatically more of the leads they receive.

Mass tort campaigns draw on a small number of channels, each with different strengths. Search advertising reaches people who are actively typing questions about a product or a diagnosis. Social advertising reaches people who match the profile of a claimant but have not searched. Online video can explain a complex product situation quickly, and short-form placements on other websites and apps round out coverage.

No single channel wins on its own. Search volume for a specific litigation can be small, social audiences need time and testing to convert, and video only works when the message is clear in the first few seconds. The practical approach is to run the channels together, measure which one produces qualified claimants rather than just clicks, and shift budget toward what is producing cases.

Behind every campaign is a set of working parts: the written criteria, the ad copy and creative that survived the firm's review, the landing page and its consent language, the screening questions, the delivery pipeline, and the reporting that shows how each dollar performed. When a firm evaluates a provider, it is really evaluating the quality of these parts.

Two questions cut through most of the noise. First, can you show me the exact screening questions claimants answer before I ever see the lead? Second, do you have a written policy on what happens when a lead does not meet the criteria? Providers with strong answers to both are worth a conversation. Providers who cannot answer either are selling traffic, not lead generation.

A car accident lead is a person with an emergency: they need a lawyer now and will often hire the first competent firm that calls. A mass tort lead is a person with a grievance: the harm happened in the past, the money is uncertain and far away, and the person is usually not in a hurry. That difference shapes every stage of lead generation for the two practice areas.

For the firm, it means mass tort intake is more patient, more educational, and more dependent on follow-up. It also means lead quality is judged differently. A mass tort lead that matches every criterion but takes six touches to reach is a good lead. The same behavior in personal injury intake would be a warning sign. Firms that import an accident-style script into mass tort intake usually lose cases they should have signed.

Claimants often arrive confused about the difference, and intake needs a simple answer ready. In a class action, a court process binds together a group of claims and the individuals in it generally do not pick their own lawyer. In a mass tort, each claimant files an individual claim, keeps an individual lawyer, and the facts of each person's case matter on their own.

That difference is the whole reason a mass tort lead has value to a firm: the claimant is becoming a client of that firm, not a name on a court-administered list. It also means the firm's screening matters more, because each claim stands on its own facts. Intake scripts that explain this distinction clearly tend to produce calmer, better-informed conversations and fewer drop-offs.

In most mass torts, the case rises or falls on medical documentation: a prescription record, an implant record, a pathology report, or a diagnosis in a chart. Screening questions are built to find that documentation. A claimant who says they were diagnosed is different from a claimant who can name the doctor and the year, and both are different from a claimant who believes their symptoms were caused by the product.

The provider's job is to ask the questions the litigation requires and pass along the answers faithfully. The firm's job is to verify. That is why the delivered lead must include the claimant's full answers, not a summary. When a firm can see exactly what the claimant said at screening, the intake call becomes a confirmation rather than an interrogation, and the conversation moves faster.

Firms that get the most from mass tort campaigns adapt intake to the campaign before it launches. That means loading the litigation's criteria into the intake script, preparing answers to the questions claimants ask most, deciding in advance what happens when a claimant almost matches, and agreeing on how many follow-up attempts happen before a lead is marked unreachable.

It also means covering evenings and weekends. Claimants answer screening at nine in the evening because that is when they are scrolling. A campaign that delivers leads around the clock needs an intake operation that responds around the clock, or the delivery advantage disappears. A short intake playbook written before the first lead arrives is one of the cheapest improvements a firm can make.

A provider earns its role by doing the marketing work that law firms cannot and should not do themselves: running the channels, building and testing the pages, keeping the consent records, screening to the firm's criteria, and delivering exclusively. The firm approves the message, sets the criteria, and owns the client relationship. The division of labor should be that clean.

Lead Search Pros builds every campaign this way. Screening questions are built from the firm's written criteria before launch. Every lead includes the source page, timestamp, IP address, consent, and the claimant's answers. Leads from each campaign go to one firm. If a lead turns out to be a wrong number, a duplicate, a solicitor, or outside the agreed criteria, and the firm reports it within 72 hours, it is replaced free. The policy is published on our lead policy page so firms can read it before they buy.

When a campaign disappoints, the cause is usually one of a few recurring problems. The criteria were never written down, so screening drifted. The intake team waited a day or more before calling. The firm judged the campaign on clicks instead of qualified claimants. The advertising promised an outcome, which attracts the wrong people and creates compliance risk. Or the lead was shared with multiple firms, so the claimant had already signed elsewhere.

Each of these is fixable, and none of them requires more traffic. The order of operations matters: criteria first, then advertising and pages, then screening, then delivery, then intake. When a firm fixes the earlier steps, the later ones stop being blamed for problems they did not cause.

The number that matters in a mass tort campaign is cost per signed case, not cost per lead and not cost per click. A cheap lead that never signs is the most expensive thing you can buy, and an expensive lead that matches every criterion and signs is cheap by comparison. Every campaign report should be read through that lens.

Give a campaign enough time to produce that number honestly. Signed cases lag delivery by weeks in mass torts, because intake is patient by nature. Firms that judge a campaign in its first few days almost always misread it. Set the review schedule before launch: weekly delivery and qualification counts, monthly cost per signed case, and a written decision point for scaling or pausing.

Before the first lead is delivered, a firm should be able to answer yes to a short list. Do we have the litigation's criteria in writing, with exclusions? Have we approved the exact ad and landing page language? Do we know the screening questions claimants will answer? Do we know who receives leads and how fast they respond, including nights and weekends? Do we have a written follow-up cadence and a place to record every touch? And do we know the replacement terms before we spend?

Firms that can answer all of these usually launch clean and sign at a healthy rate. Firms that cannot answer them usually spend the first month of the campaign discovering what they should have decided beforehand. The checklist takes an afternoon; skipping it costs a month.